Published in J Gen Virol on May 01, 1995
African swine fever virus is wrapped by the endoplasmic reticulum. J Virol (1998) 1.63
Involvement of the endoplasmic reticulum in the assembly and envelopment of African swine fever virus. J Virol (1996) 1.30
The 131-amino-acid repeat region of the essential 39-kilodalton core protein of fowlpox virus FP9, equivalent to vaccinia virus A4L protein, is nonessential and highly immunogenic. J Virol (1998) 1.14
Inhibition of a large double-stranded DNA virus by MxA protein. J Virol (2008) 1.10
Transport of African swine fever virus from assembly sites to the plasma membrane is dependent on microtubules and conventional kinesin. J Virol (2004) 1.10
The major structural protein of African swine fever virus, p73, is packaged into large structures, indicative of viral capsid or matrix precursors, on the endoplasmic reticulum. J Virol (1998) 1.09
The trans Golgi network is lost from cells infected with African swine fever virus. J Virol (2001) 0.86
African swine fever virus causes microtubule-dependent dispersal of the trans-golgi network and slows delivery of membrane protein to the plasma membrane. J Virol (2006) 0.80
Comprehensive phylogenetic reconstructions of African swine fever virus: proposal for a new classification and molecular dating of the virus. PLoS One (2013) 0.76
General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J Virol (1984) 10.98
Vaccinia virus: a selectable eukaryotic cloning and expression vector. Proc Natl Acad Sci U S A (1982) 7.81
Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proc Natl Acad Sci U S A (1985) 5.42
Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen. Nature (1983) 5.25
Triggering of acute myocardial infarction onset by episodes of anger. Determinants of Myocardial Infarction Onset Study Investigators. Circulation (1995) 5.06
Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza hemagglutinin gene and induces resistance to influenza virus infection in hamsters. Proc Natl Acad Sci U S A (1983) 4.69
Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nat Med (1998) 4.13
Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNA. Gene (1983) 3.94
A46R and A52R from vaccinia virus are antagonists of host IL-1 and toll-like receptor signaling. Proc Natl Acad Sci U S A (2000) 3.69
Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature (1985) 3.62
Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell (1995) 3.51
A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell (1992) 3.36
Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells. Nature (1984) 3.21
Live recombinant vaccinia virus protects chimpanzees against hepatitis B. Nature (1984) 3.03
Vaccinia virus gene A36R encodes a M(r) 43-50 K protein on the surface of extracellular enveloped virus. Virology (1994) 2.89
The effects of metabolic inhibition on intracellular calcium and pH in isolated rat ventricular cells. J Physiol (1989) 2.86
Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38. Science (1993) 2.85
Vaccinia virus expression vectors. J Gen Virol (1986) 2.84
Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med (1979) 2.82
Consensus criteria for traumatic grief. A preliminary empirical test. Br J Psychiatry (1999) 2.75
Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses. J Exp Med (1988) 2.73
A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope. Virology (1992) 2.67
The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence. Virology (1993) 2.66
Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: implications for use as a human vaccine. J Gen Virol (1998) 2.55
IPTG-dependent vaccinia virus: identification of a virus protein enabling virion envelopment by Golgi membrane and egress. Nucleic Acids Res (1990) 2.41
Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress. J Virol (1992) 2.35
Candidate for immunoglobulin D present on murine B lymphocytes. Nature (1974) 2.29
Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein. Science (1987) 2.24
Immunoglobulin M biosynthesis. Intracellular accumulation of 7S subunits. Biochem J (1969) 2.24
Vaccinia virus intracellular mature virions contain only one lipid membrane. J Virol (1999) 2.24
Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes. J Gen Virol (1986) 2.16
Intracellular and extracellular vaccinia virions enter cells by different mechanisms. J Gen Virol (1998) 2.14
Vaccinia virus utilizes microtubules for movement to the cell surface. J Cell Biol (2001) 2.10
The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN. J Virol (2000) 2.08
Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. J Virol (1995) 2.07
EGTA purity and the buffering of calcium ions in physiological solutions. Am J Physiol (1984) 2.03
Transient inhibition of polyoma virus synthesis by Sendai virus (parainfluenza I). I. Demonstration and nature of the inhibition by inactivated virus. J Virol (1972) 2.01
Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus. J Virol (1996) 2.01
Sequential expression of immunoglobulin on developing mouse B lymphocytes: a systematic survey that suggests a model for the generation of immunoglobulin isotype diversity. J Immunol (1978) 1.99
Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope. Proc Natl Acad Sci U S A (1998) 1.97
Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res (1993) 1.96
Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. J Immunol (1998) 1.94
Spread of prostatic cancer to bone. Urology (1983) 1.94
Seizures associated with antidepressants: a review. J Clin Psychiatry (1993) 1.91
A novel virus binding assay using confocal microscopy: demonstration that the intracellular and extracellular vaccinia virions bind to different cellular receptors. J Virol (1997) 1.86
Inhibition of spleen cell DNA synthesis by autologous macrophages. J Immunol (1966) 1.84
Roles of vaccinia virus EEV-specific proteins in intracellular actin tail formation and low pH-induced cell-cell fusion. J Gen Virol (1998) 1.81
K201 modulates excitation-contraction coupling and spontaneous Ca2+ release in normal adult rabbit ventricular cardiomyocytes. Cardiovasc Res (2007) 1.76
Inducible gene expression from vaccinia virus vectors. Virology (1990) 1.76
Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime. Vaccine (1998) 1.74
Hepatitis B virus large surface protein is not secreted but is immunogenic when selectively expressed by recombinant vaccinia virus. J Virol (1986) 1.73
An IkappaB homolog encoded by African swine fever virus provides a novel mechanism for downregulation of proinflammatory cytokine responses in host macrophages. J Virol (1996) 1.73
Inverse relation between prostate-specific antigen and insulin-like growth factor-binding protein 3 in bone metastases and serum of patients with prostate cancer. Lancet (1999) 1.70
Interactions between vaccinia virus IEV membrane proteins and their roles in IEV assembly and actin tail formation. J Virol (1999) 1.68
Cytokine receptors encoded by poxviruses: a lesson in cytokine biology. Immunol Today (1995) 1.68
Comparative risks and costs of male and female sterilization. Am J Public Health (1985) 1.65
Potentiometric measurements of stoichiometric and apparent affinity constants of EGTA for protons and divalent ions including calcium. Biochim Biophys Acta (1985) 1.65
Recognition of cloned influenza virus hemagglutinin gene products by cytotoxic T lymphocytes. J Virol (1986) 1.62
Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using recombinant vaccinia virus. J Clin Pathol (1990) 1.57
Calcium-induced calcium release activates contraction in intact cardiac cells. Pflugers Arch (1989) 1.57
The vaccinia virus A36R protein is a type Ib membrane protein present on intracellular but not extracellular enveloped virus particles. Virology (2000) 1.56
Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1beta-converting enzyme and protects virus-infected cells from TNF- and Fas-mediated apoptosis, but does not prevent IL-1beta-induced fever. J Gen Virol (1997) 1.54
Suramin, an active drug for prostate cancer: interim observations in a phase I trial. J Natl Cancer Inst (1993) 1.54
Assembly of immunoglobulin M. Blocked thiol groups of intracellular 7S subunits. Biochem J (1971) 1.53
Mutagenesis of cauliflower mosaic virus. Gene (1983) 1.53
Bladder cancer and squamous metaplasia in spinal cord injury patients. J Urol (1977) 1.53
The vaccinia virus A27L protein is needed for the microtubule-dependent transport of intracellular mature virus particles. J Gen Virol (2000) 1.52
Immunoglobulin M biosynthesis. Production of intermediates and excess of light-chain in mouse myeloma MOPC 104E. Biochem J (1971) 1.51
Vaccinia virus gene B1R encodes a 34-kDa serine/threonine protein kinase that localizes in cytoplasmic factories and is packaged into virions. Virology (1992) 1.50
Changing proteins on the surface of a parasitic nematode. Nature (1980) 1.50
Antibodies against vaccinia virus do not neutralize extracellular enveloped virus but prevent virus release from infected cells and comet formation. J Gen Virol (1997) 1.49
The genome sequence of Yaba-like disease virus, a yatapoxvirus. Virology (2001) 1.48
Electron microscopic studies of mouse immunoglobulin M; structure and reconstitution following reduction. Immunology (1970) 1.48
The influence of tackle parameters on the propensity for injury in international football. Am J Sports Med (2004) 1.47
Lack of HIV infection and condom use in licensed prostitutes. Lancet (1986) 1.46
Vaccinia virus strains Lister, USSR and Evans express soluble and cell-surface tumour necrosis factor receptors. J Gen Virol (1999) 1.46
Preliminary studies of absorption and excretion of benoxaprofen in man. Br J Clin Pharmacol (1977) 1.46
Replication of the influenza virus genome. Virology (1982) 1.45
Ontogeny of Ia and IgD on IgM-bearing B lymphocytes in mice. J Exp Med (1977) 1.44
Preparation and properties of a cytotoxic monoclonal rat anti-mouse Thy-1 antibody. J Immunol Methods (1982) 1.43
Plasmodium knowlesi sporozoite antigen: expression by infectious recombinant vaccinia virus. Science (1984) 1.42
S100A1: a regulator of myocardial contractility. Proc Natl Acad Sci U S A (2001) 1.42
A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis. The Cysticercosis Working Group in Peru. Trans R Soc Trop Med Hyg (1998) 1.41
Generation of immunoglobulin class diversity in b cells: a discussion with emphasis on idg development. Ann Immunol (Paris) (1976) 1.40
Testicular prosthesis placement: a new technique. BJU Int (1999) 1.40
The use of bladder for total transplant ureteral reconstruction. J Urol (1998) 1.40
Apoptotic versus proliferative activities in human benign prostatic hyperplasia. Hum Pathol (1996) 1.39
A mechanism for the inhibition of fever by a virus. Proc Natl Acad Sci U S A (1996) 1.39
A viral mechanism for inhibition of the cellular phosphatase calcineurin. Science (1998) 1.39
Influence of traumatic grief on suicidal ideation among young adults. Am J Psychiatry (1999) 1.38
Field evaluation of Haemophilus somnus bacterin. Vet Med Small Anim Clin (1977) 1.38
Vaccinia virus F12L protein is required for actin tail formation, normal plaque size, and virulence. J Virol (2000) 1.38
Circumcision as a risk factor for urethritis in racial groups. Am J Public Health (1987) 1.38
Preparation and characterisation of an antiserum to the mouse candidate for immunoglobulin D. Nature (1976) 1.38
The relationship between intracellular calcium and contraction in calcium-overloaded ferret papillary muscles. J Physiol (1985) 1.37
Purified multiplication-stimulating activity from rat liver cell conditioned medium: comparison of biological activities with calf serum, insulin, and somatomedin. J Cell Physiol (1974) 1.37